Mutation detection by pyrosequencing: Sequencing of exons 5-8 of the p53 tumor suppressor gene

Gene

Volumn 253, Issue 2, 2000, Pages 249-257

  Garcia, Carlos A ^a   Ahmadian, Afshin ^a   Gharizadeh, Baback ^a   Lundeberg, Joakim ^a   Ronaghi, Mostafa ^b   Nyrén, Pål ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b heteroStanford University   (Sweden)

Author keywords

Bioluminometric assay; Cancer; DNA sequencing; Multiplex PCR

Indexed keywords

PROTEIN P53;

ACCURACY; ALLELE; ANALYTIC METHOD; ARTICLE; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE MUTATION; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DNA, SINGLE-STRANDED; EXONS; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; TEMPLATES, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034622620     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(00)00257-2     Document Type: Article

References (29)

1. Ahmadian A., Lundeberg J., Nyrén P., Uhlén M., Ronaghi M. Analysis of the p53 tumor suppresor gene by pyrosequencing. BiotechniQC 28:2000;140-147.
2. Ahrendt S., Halachmi S., Chow J., Wu L., Halachmi N., Yang S., Wehage S., Jen J., Sidransky D. Rapid sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc. Natl. Acad. Sci. USA. 96:1999;7382-7387.
3. Berg C., Hedrum A., Holmberg A., Ponten F., Uhlén M., Lundeberg J. Direct solid-phase sequence analysis of the human p53 gene by use of multiplex polymerase chain reaction and α-thiotriphosphate nucleotides. Clin. Chem. 41:1995;1461-1466.
4. Berkenkamp S., Kirpekar F., Hillenkamp F. Infrared MALDI mass spectrometry of large nucleic acids. Science. 281:1998;260-262.
5. Caron de Fromentel C., Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer. 4:1992;1-15.
6. Donehower L., Harvey M., Slagle B., McArthur M., Montgomery C.A., Butel J., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
7. Feinstein E., Gale R., Reed J., Cannani E. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene. 7:1992;1853-1857.
8. Finlay C., Hinds P., Levine A. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 57:1989;1083-1093.
9. Ginsberg D., Mechta F., Yaniv M., Oren M. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA. 88:1991;9979-9983.
10. Hainaut P., Soussi T., Shomer B., Hollstein M., Greenblatt M., Hovig E., Harris C., Montesano R. Database of p53 somatic mutations in human tumors and cell lines: update compilation and future prospects. Nucleic Acids Res. 25:1997;151-157.
11. Hartmann A., Blaszyk H., McGovern R.M., Schroeder J.J., Cunningham J., De Vries E.M., Kovach J.S., Sommer S.S. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene. 10:1995;681-688.
12. Hedrum A., Pontén F., Ren Z., Lundeberg J., Pontén J., Uhlén M. Sequence-based analysis of the human p53 gene based on microdissection of tumor biopsy samples. BiotechniQC 17:1994;118-129.
13. Karamohamed S., Nilsson J., Nourizad K., Ronaghi M., Pettersson B., Nyrén P. Production, purification and luminometric analysis of recombinant Saccharomyces cerevisiae MET3 adenosine triphosphate sulfurylase expressed in Escherichia coli. Protein Expr. Purif. 15:1999;381-388.
14. Kern S.E., Pietenpol J.A., Thiagalingam S., Seymour A., Kinzler K.W., Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science. 256:1992;827-830.
15. Levine A., Perry M., Chang A., Silver A., Dittmer D., Wu M., Welsh D. The 1993 Walter Hubert Lecture: The role of the p53 tumor-suppressor gene in tumorigenesis. Br. J. Cancer. 69:1994;409-416.
16. Malkin D., Li F.P., Strong L.C., Fraumeni J.F., Nelson C.E., Kim D.H., Kassel J., Gryka M.A., Bischoff F.Z., Tainsky M.A., Friend S.A. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science. 250:1990;1233-1238.
17. Mansur C. The regulation and function of the p53 tumor suppressor. Adv. Dermatol. 13:1998;121-165.
18. McBride O., Merry D., Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc. Natl. Acad. Sci. USA. 83:1986;130-134.
19. Merzak A., Raynal S., Roger J., Lawrence D., Pilkington G. Human wild type p53 inhibits cell proliferation and elicits dramatic morphological changes in human glioma cell lines in vitro. J. Neurol. Sci. 127:1994;125-133.
20. Metzker M.L., Raghavachari R., Richards S., Jacutin S.E., Civitello A., Burgess K., Gibbs R.A. Termination of DNA synthesis by novel 3′-modified-deoxyribonucleoside 5′-triphosphates. Nucleic Acids Res. 22:1994;4259-4267.
21. Oren M. Relationship of p53 to the control of apoptotic cell death. Semin. Cancer Biol. 5:1994;221-227.
22. Peller S. Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response. Semin. Cancer Biol. 8:1998;379-387.
23. Ren Z.P., Ahmadian A., Pontén F., Nister M., Berg C., Lundeberg J., Uhlén M., Pontén J. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am. J. Pathol. 150:1997;1791-1803.
24. Ronaghi M., Nygren M., Lundeberg J., Nyrén P. Analysis of secondary structure in DNA by pyrosequencing. Anal. Biochem. 267:1999;65-71.
25. Ronaghi M., Uhlén M., Nyrén P. A sequencing method based on real-time pyrophosphate. Science. 281:1998;363-365.
26. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
27. Sterky F., et al. Gene discovery in the wood-forming tissues of poplar: analysis of 5,692 expressed sequence tags. Proc. Natl. Acad. Sci. USA. 95:1998;13330-13335.
28. Strezoska Z., Paunesku T., Radosavljevic D., Labat I., Drmanac R., Crkvenjakov R. DNA sequencing by hybridization: 100 bases read by a non-gel-based method. Proc. Natl. Acad. Sci. USA. 88:1991;10089-10093.
29. Williams C., Norberg T., Ahmadian A., Pontén F., Bergh J., Inganäs M., Lundeberg J., Uhlén M. Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets. Clin. Chem. 44:1998;455-462.